|
Bliss GVS Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
1648.40 Cr.
|
P/BV
|
1.63
|
Book Value (Rs.)
|
95.74
|
|
52 Week High/Low (Rs.)
|
186/103
|
FV/ML
|
1/1
|
P/E(X)
|
19.55
|
|
Bookclosure
|
25/07/2024
|
EPS (Rs.)
|
7.99
|
Div Yield (%)
|
0.32
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 809.73 | 765.91 | 747.43 | 737.93 | 568.69 |
| Other Operating Revenues | 0.00 | 4.34 | 4.16 | 9.53 | 8.52 |
| Total Operating Revenues | 809.73 | 770.24 | 751.59 | 747.45 | 577.21 |
| | | | | | |
| Other Income | 36.49 | 28.74 | 17.79 | 31.49 | 20.22 |
| Total Revenue | 846.22 | 798.98 | 769.37 | 778.95 | 597.43 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 372.51 | 339.12 | 330.04 | 385.27 | 259.81 |
| Purchase Of Stock-In Trade | 49.29 | 51.35 | 44.34 | 34.91 | 80.98 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -8.11 | -8.35 | 26.94 | -29.20 | -11.88 |
| Employee Benefit Expenses | 112.05 | 95.58 | 86.17 | 76.15 | 68.09 |
| Finance Costs | 8.12 | 6.91 | 10.36 | 4.74 | 5.51 |
| Depreciation And Amortisation Expenses | 29.42 | 26.38 | 18.67 | 17.33 | 17.23 |
| Other Expenses | 157.30 | 141.92 | 146.77 | 161.98 | 73.56 |
| Total Expenses | 720.58 | 652.91 | 663.30 | 651.19 | 493.30 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 125.64 | 146.07 | 106.07 | 127.76 | 104.13 |
| | | | | | |
| Exceptional Items | 0.00 | -29.20 | 0.00 | -73.59 | 0.00 |
| Profit/Loss Before Tax | 125.64 | 116.87 | 106.07 | 54.17 | 104.13 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 35.38 | 32.40 | 40.75 | 39.14 | 26.04 |
| Deferred Tax | 0.00 | 2.03 | -11.51 | -4.74 | 1.23 |
| Tax For Earlier Years | 0.00 | 0.86 | 0.09 | -3.35 | 2.88 |
| Total Tax Expenses | 35.38 | 35.29 | 29.34 | 31.04 | 30.16 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 90.26 | 81.58 | 76.73 | 23.13 | 73.97 |
| | | | | | |
| Profit/Loss From Continuing Operations | 90.26 | 81.58 | 76.73 | 23.13 | 73.97 |
| | | | | | |
| Profit/Loss For The Period | 90.26 | 81.58 | 76.73 | 23.13 | 73.97 |
| | | | | | |
| Minority Interest | -5.96 | -6.12 | -5.88 | -8.09 | -5.48 |
| Consolidated Profit/Loss After MI And Associates | 84.30 | 75.45 | 70.86 | 15.04 | 68.49 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 8.02 | 7.23 | 6.83 | 1.46 | 6.64 |
| Diluted EPS (Rs.) | 7.95 | 7.11 | 6.72 | 1.43 | 6.49 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 5.21 | 5.19 | 5.18 | 5.16 |
